PTX Media related, page-1071

Some really good research and discussion about the possibilities for PTX on this discussion thread.

Over the last few days I have heard on the radio and on TV statements about Monash Uni and Peter Mac working on T-Cell research on solid tumours. This made me think about one of IMU's current trials: "Novel combination use of FDA-approved cellular immunotherapy (CD19-CAR T cells) along with OV that presents CAR target, CD19, on solid tumors."



Given PTX's recent T-Cell cooperation with the Peter Mac Cancer Research Centre, I am starting to wonder whether PTX's products may have a part to play in the research being conducted by Monash Uni. I seems logical that Peter Mac may be promoting the PTX T-Cell platform they help PTX develop. Time will tell.

Also, PTX announced a Revised Securities Trading Policy on 27 Feb 2023. This announcement didn't raise a lot of attention but I did wonder why!!! My guess is that some exciting news is likely to unfold throughout 2023 and the company wanted to remind all staff of keeping things confidential and not to be using inside information for gain.

Good to see March arrive and PTX news starting to flow again.

GLTAHs